Company intelligence / Profile preview

STI Medical Systems

Honolulu, Hawaii, United Statessec.gov ↗

Ownership: Private
Development stage: Commercial

Overview

STI Medical Systems developed and commercialized the ImageSenseTM intelligent medical imaging system, which received FDA clearance in 2011 for use with colposcopy to assist physicians in maximizing diagnostic accuracy for cervical cancer. No recent clinical results or updates are available.[3][6]

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic imaging system
Industry: Medical Imaging

Beyond the preview

Go deeper on STI Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STI Medical Systems.

Explore the full profile